FDA to Discuss COVID-19 ’s Impact on Medical Product Operations at SBIA REdI Annual Conference
FDA will co-host the Small Business Industry and Assistance (SBIA) Regulatory Education for Industry (REdI) Annual Conference, which will provide an overview of our regulatory operations during COVID-19.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Conferences | COVID-19 | Drugs & Pharmacology | Education | Small Businesses | Universities & Medical Training